Fluorescence in situ hybridization (FISH) is an essential ancillary study used to identify clinically aggressive subsets of large B-cell lymphomas that have MYC, BCL2, or BCL6 rearrangements. The gene discussed is BCL6; the disease is B-cell non-Hodgkin lymphoma.